ASCO and IMS Health: Trends in the Cancer Care Market
Tomorrow kicks off one of the year’s largest oncology conferences: the American Society of Clinical Oncology ...
Crystal Research CEO Speaks With ABC News/Al Jazeera on JNJ Settlement
On Tuesday, Jeffrey Kraws, senior pharmaceutical analyst at Crystal Research Associates, spoke with ABC News ...
Is Pharma Forecasting No Longer to be Trusted? McKinsey & Co. says Yes.
Developing sales forecasts has long been a crucial piece of the pharmaceutical development puzzle. Pharma ...
Jeff Kraws Talks Opportunities for Biotech Investors
Biotechnology--the use of living organisms or other biological systems in the manufacture of drugs or other ...
Russian Biotech Sector is Good News for U.S. Companies
An article published last week on FierceBiotech described Russia's current biotech focus and the ...
AtheroNova Initiates Phase I Trial of AHRO-001
Today, AtheroNova Inc. (AHRO-OTC) announced that it has initiated a Phase I clinical trial with AHRO-001, the ...
2Q Cleantech Investments of $1.6 billion Target Resource Efficiency
Amid a depressed global economic environment, investments in cleantech were estimated to total $1.6 billion ...
QUARTERLY UPDATE: AtheroNova (AHRO-OTC) Receives Key Patent Allowance
Novel biotech company AtheroNova Inc. (AHRO-OTC) made a significant news announcement last week when it ...
"Devices hurt by Obamacare, hospitals win: Kraws" (Replay and Transcript)
This morning, Crystal Research CEO Jeff Kraws spoke with Reuters' Rhonda Schaffler about winners and losers ...
APDN’s Anti-Counterfeiting Technology Addresses New Federal Legislation
A significant opportunity has arisen for Applied DNA Sciences (APDN-OTC) and its anti-counterfeiting and ...
CEL-SCI Continues Advancing to the Start of Phase III Trials for Multikine
This morning, CEL-SCI Corp. (CVM-NYSE Amex) announced the completion of its clinical investigator meeting ...
Advances in Alzheimer’s Research Fuels the Development of Possible Treatments
On November 1, 2010, the Pharmaceutical Research and Manufacturers of America (PhRMA) issued a press release ...
University of Texas Selects WordLogic Text Entry System for Texas Technology Access Program
Today, a company under our research coverage, WordLogic Corp. (WLGC-OTC) announced that the Texas Technology ...